Very polished presentation, in both design and content. Totally answers all of the questions I had about the heart failure announcement from the other day. Well done to EchoIQ.
I suppose it is a reasonable bet that the release of the presentation has something to do with raising capital. Though there are several other plausible explanations for today's release of a glossy: one being by releasing the presentation the company is allowed to engage with interested commercial parties about all the latest developments and projections without being accused of divulging inside information; another possible reason is that they can hand out the glossy's contents to medicos at that conference in New York in early June, again without there being an inside info risk.
Particularly like that they gave an indicative timeline for commercialisation regarding heart failure (feasible within 12 months) though a tad curious they did not repeat in the presentation what they claimed in recent ASX announcements: that they expect FDA to take no more than 90 days for ticking off on the aortic stenosis test. (Woohoo 5 August!). Also a bit odd that Profs Strange and Playford seem not to have been given any exposure in the presentation given their scientific cred and significant contributions.
EIQ Price at posting:
15.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)